The U.K. dominated the Europe pelvic reconstruction market is expected to witness steady growth through 2022 & beyond. Growth in the market is underpinned by rising cases of pelvic floor disorders in the country
NEWARK, Del, Aug. 29, 2022 (GLOBE NEWSWIRE) -- As per Future Market Insights, the global pelvic reconstruction market was around US$ 270.5 Mn in 2021 and is projected to exhibit at CAGR of 2.8% over the forecast period (2022-2032), surpassing US$ 366.9 Mn in 2032. Growth is due to the increased use of vaginal mesh, slings, and pessaries in the healthcare sector owing to rising cases of pelvic floor disorders.
Furthermore, increasing awareness regarding vaginal health due to growing cases of pelvic disorders and deformities have surged the need for pelvic reconstruction products. On the back of this, key players are vying to develop systems that can be approved by regulatory authorities such as the FDA.
Additionally, growing acceptance of pelvic floor reconstruction procedures in hospitals and specialty clinics is prompting the adoption of advanced systems for accurate and speedy recovery. There is also an increase in the research and development on ways to handle pelvic floor disorders by mitigating the risk factors.
Request a Sample PDF Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15500
Increasing use of tissue engineering to support pelvic floor and also promotes tissue repair. This is also highly biocompatible compared to the general approach of using polypropylene mesh. Hence, several ongoing research is focusing on tissue engineering such as the use of fibroblasts and stem cells is supporting the growth in pelvic reconstruction market.
Key Takeaways from Market Study
Based on product type, vaginal sling systems held approximately 54.2% market value share in 2021, owing to rising cases of pelvic floor disorders.
Surgical procedure is set to lead the market, in terms of procedures, and contributed around 78.9% of revenue in 2021.
By indication, pelvic organ prolapse is expected to register growth at a CAGR of 2.7% during the forecast period.
By pelvic organs, the vagina is the most affected organ and the segment held a share of about 38.6% in 2021.
North America is considered as the leading region with a value share of 33.9% in 2021, owing to the high prevalence of pelvic floor disorders in the region.
“Rising initiatives to promote safety and mitigate risk, as well as the increasing research and development for the improvement of treatment approaches is set to propel the sales of pelvic reconstruction products across the globe,” says an analyst of Future Market Insights.
For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-15500
The market for pelvic reconstruction consists of a number of local as well as established players within the market sphere. There is increased research and development to meet the current needs of the population.
In 2019, as per research conducted by Royal Hallamshire Hospital, UK, Ulrich et al. demonstrated that endometrial MSCs seeded onto gelatin-coated polyamide mesh had an anti-inflammatory effect and promoted neovascularization in a rat model.
Onkos Surgical declared in July 2022 that its My3D® Personalized Pelvic Reconstruction system had been granted 510(k) approval.
Key Companies Profiled in the Study are –
Johnson & Johnson Services, Inc.
Boston Scientific Corporation (American Medical Systems Inc.)
Talk to Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-15500
Key Market Segments Covered in Pelvic Reconstruction Market Research:
Native Tissue Repair (uterosacral ligament suspension and sacrospinous fixation)
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
Get detailed TOC @ https://www.futuremarketinsights.com/toc/rep-gb-15500
Have a Look at Related Research Reports of Healthcare
Female Pelvic Implants Market Size : The female pelvic implants market is expected to surpass US$ 331.96 Mn by 2032.
Knee Reconstruction Devices Market Research : Global knee reconstruction devices market is expected to gain impetus from expanding geriatric populations & incidence of bone and joint ailments, expanding at a healthy CAGR of close to 6% through 2031.
Breast Reconstruction Surgery and Treatment Market Insights : The breast reconstruction surgery and treatment market are predicted to expand at a CAGR of 2.7% during the forecast period, with a predicted value of US$ 647 million in 2026.
Neurology Services Market Forecast : The global neurology services market is expected to reach a valuation of US$ 2,562.8 Bn by the end of 2022, and further expand at a CAGR of 5.4% from 2022 to 2032. The market is likely to reach a valuation of ~US$ 4,317.8 Bn by 2032.
Oxygen Conservation Devices Market Analysis : The oxygen conservation devices market is anticipated to have an effective CAGR of 11.1% during the period of 2022-2032.
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Future Market Insights Inc. Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, USA T: +1-845-579-5705 For Sales Enquiries: sales@futuremarketinsights.com Browse latest Market Reports: https://www.futuremarketinsights.com/reports
Follow Buffett’s lead. And collect big dividends too.
‘Rich Dad Poor Dad’ sees a window to get rich. He might be right.
Cathie Wood's ARK Invest cut its stake in Nvidia ahead of the graphic chipmaker's results last month. Now it's snapped up the stock which has dropped to a 52-week low.
Chinese stocks have come under pressure for various reasons over the past year and a half or so; a slowing economy has been one cause while domestic tussles with the regulators haven’t helped either, particularly for those in the tech sector. Another element keeping sentiment low and impacting performance has been the fear of de-listing for U.S.-listed Chinese stocks. This is on account of Chinese companies not meeting U.S. auditing standards. But the prospects of de-listing might be less likely
Orchid Island Capital Corp. (NYSE: ORC) is a finance company that acquires, invests in and offers financing from U.S. residential mortgage-backed securities (MBS). The Florida mortgage real estate investment trust (REIT) initiated an IPO in March 2013 at a price of $14.50. Its monthly dividend of $0.135 returned an approximate annual yield of 11%. However, in the last few years, the stock price has floundered, and ORC has reduced its dividend payment several times. Orchid’s price had recently be
(Bloomberg) -- Stocks are falling and bond yields are rising, but markets still don’t seem convinced the Federal Reserve will pursue plans to keep increasing interest rates until inflation is under control, said Sonal Desai, chief investment officer for fixed income at Franklin Templeton Cos. “The Fed lacks credibility,” Desai said on Bloomberg Television’s “Wall Street Week” on Friday. “Markets don’t believe that the Fed is going to do what the Fed keeps saying it’s going to do.”The S&P 500 clo
Finally, investors have a good reason for why the U.S. stock market will suffer above-average volatility and below-average performance this month: It’s the Fed. Relatively few advisers are focusing on this outcome — at least among the more than 100 I regularly monitor.
Ready to go bottom fishing again? Any good angler can tell you that there’s plenty of good eating just waiting at the bottom of the creek, or the pond, or the lake. The same concept also holds for stocks – investors can always find some quality equities down at the market bottoms. Stocks get down there for a multitude of reasons, and the reasons aren’t always related to any fundamental flaw in the company or its share trading policies. Sometimes, it’s some idiosyncratic business move, or over-re
The S&P 500 broke below 4,000 this week, for the first time since the end of July. It has investors wondering: Does this mark the low point of a roller coaster ride? Stocks rose all last year, fell from January to June, rallied from July to mid-August, and now are falling again. According to Wells Fargo strategist Paul Christopher, it’s evidence that the stock rally is sputtering to a halt. Christopher writes that “Cracks in financial market liquidity are appearing,” and says of the S&P 500, “3,
Shat should investors do now if they are considering making a bet on the infamously volatile sector.
Electric vehicle (EV) charging network company ChargePoint Holdings (NYSE: CHPT) gave investors a mixed fiscal 2023 second-quarter earnings report earlier this week. ChargePoint exceeded the high end of its prior guidance for revenue. The company had told investors to expect revenue of between $96 million and $106 million for the period, and it achieved $108.3 million in sales.
Recently, Zacks.com users have been paying close attention to Energy Transfer LP (ET). This makes it worthwhile to examine what the stock has in store.
In this article we are going to share the list of hedge funds’ 10 best media and entertainment stocks to buy. You can skip our discussion and see the 5 Best Media Stocks To Buy here. Media and entertainment stocks have been hammered this year and this may be a good time to dip our […]
(Bloomberg) -- Investors bracing for a recession jolt accelerated their retreat from stocks after the Federal Reserve warned it won’t be easily deterred in its fight against inflation, Bank of America Corp. strategists say.Most Read from BloombergAmazon Closes, Abandons Plans for Dozens of US WarehousesGazprom Won’t Reopen Gas Pipeline in Energy Shock to EuropeStocks Suffer Third Weekly Loss on Rate-Hike Woes: Markets WrapLukoil Chairman Ravil Maganov Dies After Falling From Hospital WindowGloba
The major indexes broke more key support last week. Apple unveils the iPhone 14 Wednesday. AAPL stock is worth watching, but this tech leader looks better.
The stock plummeted after the U.S. government imposed new licensing requirements for advanced chip sales. Jefferies believes the contraction presents a buying opportunity.
Dan Niles, a money manager who has been bearish on the stock market, is even more pessimistic now. But he does see some opportunities, including in shares of Walmart and Amazon.com.
The bond market has entered its first bear market in more than 30 years — and possibly much longer. A bear market is usually defined as a loss of at least 20% from its previous peak. The bond market downturn has come due to rampant inflation in the western world, and the efforts by central banks to tame it.
Tough times are coming. But maybe not for investors.
Cathie Wood seems to have used Nvidia tough day to buy more stock in the graphics chip giant. Nvidia (ticker: NVDA) stock dropped 7.7% on Thursday after the company disclosed new licensing requirements for selling advanced semiconductors to China imposed by the U.S. government. Nvidia has said up to $400 million in third-quarter sales were at risk.